Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years.

Neurol Ther · 2024 · PMC11541067 · PMID 39378014

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Consequently, the PRIME study was highly significant, marking the first trial to show evidence of a possible correlation between the reduction of brain Aβ levels and clinical efficacy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.